BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 11264458)

  • 1. Properties and biological activities of thioredoxins.
    Powis G; Montfort WR
    Annu Rev Pharmacol Toxicol; 2001; 41():261-95. PubMed ID: 11264458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties and biological activities of thioredoxins.
    Powis G; Montfort WR
    Annu Rev Biophys Biomol Struct; 2001; 30():421-55. PubMed ID: 11441809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological functions of thioredoxin and thioredoxin reductase.
    Arnér ES; Holmgren A
    Eur J Biochem; 2000 Oct; 267(20):6102-9. PubMed ID: 11012661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Thioredoxin System for Cancer Therapy.
    Zhang J; Li X; Han X; Liu R; Fang J
    Trends Pharmacol Sci; 2017 Sep; 38(9):794-808. PubMed ID: 28648527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial thioredoxin system.
    Miranda-Vizuete A; Damdimopoulos AE; Spyrou G
    Antioxid Redox Signal; 2000; 2(4):801-10. PubMed ID: 11213484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex.
    Fritz-Wolf K; Jortzik E; Stumpf M; Preuss J; Iozef R; Rahlfs S; Becker K
    J Mol Biol; 2013 Sep; 425(18):3446-60. PubMed ID: 23845423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenium and the thioredoxin redox system: effects on cell growth and death.
    Powis G; Gasdaska JR; Gasdaska PY; Berggren M; Kirkpatrick DL; Engman L; Cotgreave IA; Angulo M; Baker A
    Oncol Res; 1997; 9(6-7):303-12. PubMed ID: 9406236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thioredoxin/thioredoxin reductase redox system and control of cell growth.
    Powis G; Oblong JE; Gasdaska PY; Berggren M; Hill SR; Kirkpatrick DL
    Oncol Res; 1994; 6(10-11):539-44. PubMed ID: 7620223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the specificity of thioredoxin reductase-thioredoxin interactions. A structural and functional investigation of the yeast thioredoxin system.
    Oliveira MA; Discola KF; Alves SV; Medrano FJ; Guimarães BG; Netto LE
    Biochemistry; 2010 Apr; 49(15):3317-26. PubMed ID: 20235561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
    Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
    Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo.
    Fang J; Holmgren A
    J Am Chem Soc; 2006 Feb; 128(6):1879-85. PubMed ID: 16464088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of thioredoxin and thioredoxin reductase.
    Arnér ES; Holmgren A
    Curr Protoc Toxicol; 2001 May; Chapter 7():Unit 7.4.. PubMed ID: 20954152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells.
    Myers CR; Myers JM
    Toxicology; 2009 Mar; 257(1-2):95-104. PubMed ID: 19135121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of the redox potentials of thioredoxin and thioredoxin reductase from Drosophila melanogaster to the enzymatic mechanism: reduced thioredoxin is the reductant of glutathione in Drosophila.
    Cheng Z; Arscott LD; Ballou DP; Williams CH
    Biochemistry; 2007 Jul; 46(26):7875-85. PubMed ID: 17550271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thioredoxin reductase-thioredoxin system is involved in the entry of tetanus and botulinum neurotoxins in the cytosol of nerve terminals.
    Pirazzini M; Bordin F; Rossetto O; Shone CC; Binz T; Montecucco C
    FEBS Lett; 2013 Jan; 587(2):150-5. PubMed ID: 23178719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thioredoxin system--from science to clinic.
    Gromer S; Urig S; Becker K
    Med Res Rev; 2004 Jan; 24(1):40-89. PubMed ID: 14595672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies toward novel peptidomimetic inhibitors of thioredoxin-thioredoxin reductase system.
    Kłossowski S; Muchowicz A; Firczuk M; Swiech M; Redzej A; Golab J; Ostaszewski R
    J Med Chem; 2012 Jan; 55(1):55-67. PubMed ID: 22128876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic insights into the inhibitory effects of palmitoylation on cytosolic thioredoxin reductase and thioredoxin.
    Qin H; Liang W; Xu Z; Ye F; Li X; Zhong L
    Biochimie; 2015 Mar; 110():25-35. PubMed ID: 25576832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic reduction of alloxan by thioredoxin and NADPH-thioredoxin reductase.
    Holmgren A; Lyckeborg C
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5149-52. PubMed ID: 6933551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mammalian testis-specific thioredoxin system.
    Miranda-Vizuete A; Sadek CM; Jiménez A; Krause WJ; Sutovsky P; Oko R
    Antioxid Redox Signal; 2004 Feb; 6(1):25-40. PubMed ID: 14713334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.